Old Web
English
Sign In
Acemap
>
authorDetail
>
Justine Dell’Aringa
Justine Dell’Aringa
Celgene
Medicine
Immunology
Antibody
Multiple myeloma
PD-L1
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies
2019
Clinical Pharmacokinectics
Ken Ogasawara
Kathryn Newhall
Stephen E. Maxwell
Justine Dell’Aringa
Vitalina Komashko
Nurgul Kilavuz
Richard Delarue
Myron S. Czuczman
Lars Sternas
Shelonitda Rose
C.L. Beach
Steven Novick
Simon Zhou
Maria Palmisano
Yan Li
Show All
Source
Cite
Save
Citations (8)
Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial
2019
Blood
Carla Casulo
Armando Santoro
Kiyoshi Ando
Steven Le Gouill
Jia Ruan
John Radford
Luca Arcaini
Antonello Pinto
Reda Bouabdallah
Koji Izutsu
Simon Rule
Javier Munoz
Marie-Laure Casadebaig
Brian Fox
Nils Rettby
Justine Dell’Aringa
Richard Delarue
Kathryn Newhall
Myron S. Czuczman
Guillaume Cartron
Show All
Source
Cite
Save
Citations (6)
Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status
2018
Blood
Greg E. Pietz
Mark Tometsko
Wilbert B. Copeland
Elizabeth Whalen
Frank Schmitz
Ethan G. Thompson
Amit Agarwal
Teresa Foy
Lauren Buchholz
Vitalina Komashko
Justine Dell’Aringa
Brian Fox
Kathryn Newhall
Show All
Source
Cite
Save
Citations (2)
1